Linezolid in the Starter Combination for Multidrug-Resistant Tuberculosis: Time to Move on to Group Four?

نویسندگان

  • Soazic Grard
  • Gaud Catho
  • Florent Valour
  • Anissa Bouaziz
  • Thomas Perpoint
  • Evelyne Braun
  • François Biron
  • Patrick Miailhes
  • Tristan Ferry
  • Christian Chidiac
  • Pierre-Jean Souquet
  • Sébastien Couraud
  • Gérard Lina
  • Sylvain Goutelle
  • Nicolas Veziris
  • Oana Dumitrescu
  • Florence Ader
  • F. Ader
  • F. Biron
  • A. Boibieux
  • A. Bouaziz
  • K. Bouledrak
  • E. Braun
  • G. Catho
  • C. Chidiac
  • W. Chumbi-Flores
  • S. Couraud
  • G. Devouassoux
  • O. Dumitrescu
  • T. Ferry
  • N. Freymond
  • S. Gardes
  • S. Gerbier-Colomban
  • Y. Gillet
  • S. Goutelle
  • J. Grando
  • R. Grima
  • L. Hees
  • V. Jubin
  • L. Kiakouama-Maleka
  • G. Lina
  • J.M. Maury
  • P. Miailhes
  • T. Perpoint
  • Em. Perrot
  • Emm Perrot
  • P. Reix
  • A.S. Renaud-Baron
  • V. Ronin
  • A. Senechal
  • P.J. Souquet
  • H. Thai Van
  • F. Tronc
  • F. Valour
  • P. Vanhems
چکیده

Linezolid (LNZ), a group 5 antituberculous drug (unclear efficacy), was used in the starter regimens of 23 adults with multidrug-resistant tuberculosis. The LNZ-containing regimens were effective in achieving culture conversions and relapse-free outcomes. The most frequent LNZ-related side effect was neuropathy. We propose that LNZ should be reclassified among bactericidal second-line drugs.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Linezolid for the treatment of multidrug-resistant tuberculosis.

OBJECTIVES In vitro studies have shown good activity of linezolid against Mycobacterium tuberculosis, including multidrug-resistant strains. However, clinical experience with linezolid in tuberculosis is scarce. METHODS We report our clinical experience with five consecutive patients with multidrug-resistant tuberculosis infection treated with combination regimens that included linezolid. R...

متن کامل

Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China.

Linezolid may be effective in treating multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. We conducted a prospective, multicentre, randomised study to further evaluate the efficacy, safety and tolerability of linezolid in patients with extensively drug-resistant tuberculosis in China. 65 patients who had culture-positive sputum for extensively drug-resistant tuberculo...

متن کامل

Linezolid for multidrug-resistant tuberculosis: How should we approach it?

Multidrug-resistant tuberculosis (MDR-TB), defined as resistance to at least rifampicin and isoniazid, poses a major threat to public health and TB control worldwide. According to the World Health Organization (WHO), MDR-TB accounted for 480,000 new cases of TB in 2013, of which 9% were extensively drug-resistant TB (XDR-TB), defined as MDR-TB with resistance to a fluoroquinolone and at least o...

متن کامل

Study of HIV seroprevalence in Pulmonary Tuberculosis Patients with Special Reference to Multidrug Resistant Mycobacteria

This study was planned to determine HIV seroprevalence among pulmonary tuberculosis patients, to characterize the isolated mycobacteria into typical and atypical strains and to evaluate the drug resistant pattern of mycobacterial isolates. The study aims to correlate multidrug resistance (MDR) and HIV seropositivity status in pulmonary tuberculosis patients. During the year 1994-1997, 750 pulmo...

متن کامل

A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis.

Linezolid is used to treat patients with multidrug-resistant (MDR)/extensively drug-resistant (XDR)-tuberculosis (TB) cases, although clinical data on its safety, tolerability and efficacy are lacking. We performed a retrospective, nonrandomised, unblinded observational study evaluating the safety and tolerability of linezolid at 600 mg q.d. or b.i.d. in MDR/XDR-TB treatment in four European co...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 2  شماره 

صفحات  -

تاریخ انتشار 2015